BXP vs EBS
Boston Properties Inc (BXP) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Boston Properties Inc (BXP) is a reit - office company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported BXP revenue for 2024-12-31 was $3.41B. Net income was $84.2M. Revenue was up 4.1% from 2023-12-31 to 2024-12-31. BXP currently screens at market cap $12.12B.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
BXP currently screens at market cap $12.12B. EBS currently screens at market cap $416.4M.
Not investment advice. Open the BXP and EBS stock pages for the full models.
Not investment advice.